Melatonin and mitochondria in aging

Abstract

The worldwide prolongation of mean life expectancy has resulted in a rapid increase of the size of the elderly population, both in numbers and as a proportion of the whole. In addition, the incidence of age-related diseases is obviously increasing as the population ages. Finding means to preserve optimal health in old age has become a primary goal of biomedical research. Aging is a multifactorial process that includes progressive cellular loss, endocrine and metabolic deficits, reduced defense mechanisms and functional losses that increase the risk of death. Mitochondria fulfill a number of essential cellular functions and play a key role in the aging process. Melatonin, which is synthesized in the pineal gland and other organs, plays a role in the biologic regulation of aging. Noctural melatonin serum levels are high during childhood and diminish substantially as people age. Melatonin preserves mitochondrial homeostasis, reduces free radical generation, e.g., by enhancing mitochondrial glutathione levels; it also safeguards proton potential and ATP synthesis by stimulating complex I and IV activities. In this article, we review the role of melatonin and mitochondria in aging.

Key words： aging; melatonin; mitochondria; respiratory; reactive oxygen species

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant No. 30472248).

References

1 Acuña C D, Escames G, Carazo A, León J, Khaldy H, Reiter R J (2002). Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr Top Med Chem, 2(2): 133-151

2 Acuña-Castroviejo D, Escames G, Rodriguez M I, Lopez L C (2007). Melatonin role in the mitochondrial function. Front Biosci, 12: 947-963

3 Acuña-Castroviejo D, Martín M, Macías M, Escames G, León J, Khaldy H, Reiter R J (2001). Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res, 30(2): 65-74

4 Acuña-Castroviejo D, Reiter R J, Menéndez-Peláez A, Pablos M I, Burgos A (1994). Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. J Pineal Res, 16(2): 100-112

5 Allegra M, Reiter R J, Tan D X, Gentile C, Tesoriere L, Livrea M A (2003). The chemistry of melatonin’s interaction with reactive species. J Pineal Res, 34(1): 1-10

6 Antolín I, Rodríguez C, Saínz R M, Mayo J C, Uría H, Kotler M L, Rodríguez-Colunga M J, Tolivia D, Menéndez-Peláez A (1996). Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J, 10(8): 882-890

7 Becker-André M, Wiesenberg I, Schaeren-Wiemers N, André E, Missbach M, Saurat J H, Carlberg C (1994). Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem, 269(46): 28531-28534

8 Benot S, Goberna R, Reiter R J, Garcia-Mauriño S, Osuna C, Guerrero J M (1999). Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res, 27(1): 59-64

9 Bondy S C, Li H, Zhou J, Wu M, Bailey J A, Lahiri D K (2010), Melatonin alters age-related changes in transcription factors and kinase activation. Neurochem Res, doi: 10.1007/s11064-010-0206-3

10 Bondy S C, Sharman E H (2007). Melatonin and the aging brain. Neurochem Int, 50(4): 571-580

11 Bowling A C, Beal M F (1995). Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci, 56(14): 1151-1171

12 Brown G C (1992). Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem J, 284(Pt 1): 1-13

13 Camello-Almaraz C, Gomez-Pinilla P J, Pozo M J, Camello P J (2008). Age-related alterations in Ca²⁺ signals and mitochondrial membrane potential in exocrine cells are prevented by melatonin. J Pineal Res, 45(2): 191-198

14 Carlberg C (2000). Gene regulation by melatonin. Ann N Y Acad Sci, 917: 387-396

15 Carranza-Lira S, García López F (2000). Melatonin and climactery. Med Sci Monit, 6(6): 1209-1212

16 Carretero M, Escames G, López L C, Venegas C, Dayoub J C, García L, Acuña-Castroviejo D (2009). Long-term melatonin administration protects brain mitochondria from aging. J Pineal Res, 47(2): 192-200

17 Carrillo-Vico A, Guerrero J M, Lardone P J, Reiter R J (2005). A review of the multiple actions of melatonin on the immune system. Endocrine, 27(2): 189-200

18 Costa E J, Shida C S, Biaggi M H, Ito A S, Lamy-Freund M T (1997). How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett, 416(1): 103-106

19 Crespo E, Macías M, Pozo D, Escames G, Martín M, Vives F, Guerrero J M, Acuña-Castroviejo D (1999). Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J, 13(12): 1537-1546

20 Dong W G, Huang F, Fan W G, Cheng S W, Chen Y, Zhang W G, Shi H, He H W (2010). Differential effects of melatonin on amyloid-beta peptide 25-35-induced mitochondrial dysfunction in hippocampal neurons at different stages of culture. J Pineal Res, 48(2): 117-125

21 Dubocovich M L, Markowska M (2005). Functional MT1 and MT2 melatonin receptors in mammals. Endocrine, 27(2): 101-110

22 Ersahin M, Toklu H Z, Cetinel S, Yüksel M, Yeğen B C, Sener G (2009). Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms. J Pineal Res, 46(3): 324-332

23 Escames G, León J, Macías M, Khaldy H, Acuña-Castroviejo D (2003). Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J, 17(8): 932-934

24 Esteban S, Garau C, Aparicio S, Moranta D, Barceló P, Fiol M A, Rial R (2010). Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J Pineal Res, 48(2): 170-177

25 Figueiredo P A, Mota M P, Appell H J, Duarte J A (2008). The role of mitochondria in aging of skeletal muscle. Biogerontology, 9(2): 67-84

26 García J J, Piñol-Ripoll G, Martínez-Ballarín E, Fuentes-Broto L, Miana-Mena F J, Venegas C, Caballero B, Escames G, Coto-Montes A, Acuña-Castroviejo D (2010). Melatonin reduces membrane rigidity and oxidative damage in the brain of SAMP(8) mice. Neurobiol Aging, doi:10.1016/j.neurobiolaging.2009.12.013

27 García J J, Reiter R J, Pié J, Ortiz G G, Cabrera J, Sáinz R M, Acuña-Castroviejo D (1999). Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J Bioenerg Biomembr, 31(6): 609-616

28 Haddad J J (2004). Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno-pharmaco-redox conception of oxidative siege versus cell death commitment. Int Immunopharmacol, 4(4): 475-493

29 Halestrap A P (2006). Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans, 34(Pt 2): 232-237

30 Hardeland R, Balzer I, Poeggeler B, Fuhrberg B, Uría H, Behrmann G, Wolf R, Meyer T J, Reiter R J (1995). On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J Pineal Res, 18(2): 104-111

31 Hardeland R, Tan D X, Reiter R J (2009). Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res, 47(2): 109-126

32 Herrera F, Martin V, García-Santos G, Rodriguez-Blanco J, Antolín I, Rodriguez C (2007). Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria. J Neurochem, 100(3): 736-746

33 Jagota A, Kalyani D (2010). Effect of melatonin on age induced changes in daily serotonin rhythms in suprachiasmatic nucleus of male Wistar rat. Biogerontology, 11(3): 299-308

34 Jou M J, Peng T I, Hsu L F, Jou S B, Reiter R J, Yang C M, Chiao C C, Lin Y F, Chen C C (2010). Visualization of melatonin’s multiple mitochondrial levels of protection against mitochondrial Ca(2+)-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res, 48(1): 20-38

35 Jou M J, Peng T I, Yu P Z, Jou S B, Reiter R J, Chen J Y, Wu H Y, Chen C C, Hsu L F (2007). Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res, 43(4): 389-403

36 Kaptanoglu E, Tuncel M, Palaoglu S, Konan A, Demirpençe E, Kilinç K (2000). Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg, 93(1 Suppl): 77-84

37 Karasek M (2007). Does melatonin play a role in aging processes? J Physiol Pharmacol, 58(Suppl 6): 105-113

38 Karasek M, Reiter R J, Cardinali D P, Pawlikowski M (2002). Future of melatonin as a therapeutic agent. Neuro Endocrinol Lett, 23(Suppl 1): 118-121

39 Karbownik M, Reiter R J, Garcia J J, Tan D X, Qi W, Manchester L C (2000a). Melatonin reduces rat hepatic macromolecular damage due to oxidative stress caused by delta-aminolevulinic acid. Biochim Biophys Acta, 1523(2-3): 140-146

40 Karbownik M, Tan D, Manchester L C, Reiter R J (2000b). Renal toxicity of the carcinogen delta-aminolevulinic acid: antioxidant effects of melatonin. Cancer Lett, 161(1): 1-7

41 Kedziora-Kornatowska K, Szewczyk-Golec K, Kozakiewicz M, Pawluk H, Czuczejko J, Kornatowski T, Bartosz G, Kedziora J (2009). Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res, 46(3): 333-337

42 Kim R, Emi M, Tanabe K (2006). Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol, 57(5): 545-553

43 Lahiri D K, Ge Y W, Sharman E H, Bondy S C (2004). Age-related changes in serum melatonin in mice: higher levels of combined melatonin and 6-hydroxymelatonin sulfate in the cerebral cortex than serum, heart, liver and kidney tissues. J Pineal Res, 36(4): 217-223

44 Lee H C, Wei Y H (1997). Role of mitochondria in human aging. J Biomed Sci, 4(6): 319-326

45 León J, Acuña-Castroviejo D, Escames G, Tan D X, Reiter R J (2005). Melatonin mitigates mitochondrial malfunction. J Pineal Res, 38(1): 1-9

46 León J, Acuña-Castroviejo D, Sainz R M, Mayo J C, Tan D X, Reiter R J (2004). Melatonin and mitochondrial function. Life Sci, 75(7): 765-790

47 Macías M, Escames G, Leon J, Coto A, Sbihi Y, Osuna A, Acuña-Castroviejo D (2003). Calreticulin-melatonin. An unexpected relationship. Eur J Biochem, 270(5): 832-840

48 Martín M, Macías M, Escames G, León J, Acuña-Castroviejo D (2000a). Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J, 14(12): 1677-1679

49 Martín M, Macías M, Escames G, Reiter R J, Agapito M T, Ortiz G G, Acuña-Castroviejo D (2000b). Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res, 28(4): 242-248

50 Martín M, Macías M, León J, Escames G, Khaldy H, Acuña-Castroviejo D (2002). Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol, 34(4): 348-357

51 Matsubara E, Bryant-Thomas T, Pacheco Quinto J, Henry T L, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan Y J, Smith M A, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson G L, Ghiso J, Williams C, Refolo L M, Pappolla M A, Chain D G, Neria E (2003). Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease. J Neurochem, 85(5): 1101-1108

52 Mecocci P, MacGarvey U, Kaufman A E, Koontz D, Shoffner J M, Wallace D C, Beal M F (1993). Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol, 34(4): 609-616

53 Menendez-Pelaez A, Reiter R J (1993). Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res, 15(2): 59-69

54 Milczarek R, Klimek J, Zelewski L (2000). Melatonin inhibits NADPH-dependent lipid peroxidation in human placental mitochondria. Horm Metab Res, 32(2): 84-85

55 Morioka N, Okatani Y, Wakatsuki A (1999). Melatonin protects against age-related DNA damage in the brains of female senescence-accelerated mice. J Pineal Res, 27(4): 202-209

56 Nosjean O, Ferro M, Coge F, Beauverger P, Henlin J M, Lefoulon F, Fauchere J L, Delagrange P, Canet E, Boutin J A (2000). Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem, 275(40): 31311-31317

57 Okatani Y, Wakatsuki A, Reiter R J (2002a). Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice. J Pineal Res, 32(3): 143-148

58 Okatani Y, Wakatsuki A, Reiter R J, Miyahara Y (2002b). Hepatic mitochondrial dysfunction in senescence-accelerated mice: correction by long-term, orally administered physiological levels of melatonin. J Pineal Res, 33(3): 127-133

59 Okatani Y, Wakatsuki A, Reiter R J, Miyahara Y (2003). Acutely administered melatonin restores hepatic mitochondrial physiology in old mice. Int J Biochem Cell Biol, 35(3): 367-375

60 Olcese J M, Cao C, Mori T, Mamcarz M B, Maxwell A, Runfeldt M J, Wang L, Zhang C, Lin X, Zhang G, Arendash G W (2009). Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res, 47(1): 82-96

61 Pang S F, Tsang C W, Hong G X, Yip P C, Tang P L, Brown G M (1990). Fluctuation of blood melatonin concentrations with age: result of changes in pineal melatonin secretion, body growth, and aging. J Pineal Res, 8(2): 179-192

62 Pappolla M A, Chyan Y J, Poeggeler B, Frangione B, Wilson G, Ghiso J, Reiter R J (2000). An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer’s disease. J Neural Transm, 107(2): 203-231

63 Paradies G, Petrosillo G, Paradies V, Reiter R J, Ruggiero F M (2010). Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res, 48(4): 297-310

64 Petrosillo G, Di Venosa N, Pistolese M, Casanova G, Tiravanti E, Colantuono G, Federici A, Paradies G, Ruggiero F M (2006). Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin. FASEB J, 20(2): 269-276

65 Petrosillo G, Fattoretti P, Matera M, Ruggiero F M, Bertoni-Freddari C, Paradies G (2008). Melatonin prevents age-related mitochondrial dysfunction in rat brain via cardiolipin protection. Rejuvenation Res, 11(5): 935-943

66 Petrosillo G, Moro N, Paradies V, Ruggiero F M, Paradies G (2010). Increased susceptibility to Ca(2+)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: effect of melatonin. J Pineal Res, 48(4): 340-346

67 Poeggeler B (2005). Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine, 27(2): 201-212

68 Reiter R J (1991). Melatonin: the chemical expression of darkness. Mol Cell Endocrinol, 79(1-3): C153-C158

69 Reiter R J (1992). The ageing pineal gland and its physiological consequences. Bioessays, 14(3): 169-175

70 Reiter R J (1998). Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol, 56(3): 359-384

71 Reiter R J, Craft C M, Johnson J E Jr, King T S, Richardson B A, Vaughan G M, Vaughan M K (1981). Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology, 109(4): 1295-1297

72 Reiter R J, Richardson B A, Johnson L Y, Ferguson B N, Dinh D T (1980). Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science, 210(4476): 1372-1373

73 Reiter R J, Tan D X (2002). Melatonin: an antioxidant in edible plants. Ann N Y Acad Sci, 957: 341-344

74 Reiter R J, Tan D X (2003). What constitutes a physiological concentration of melatonin? J Pineal Res, 34(1): 79-80

75 Reiter R J, Tan D X, Manchester L C, El-Sawi M R (2002). Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann N Y Acad Sci, 959: 238-250

76 Reiter R J, Tan D X, Pappolla M A (2004). Melatonin relieves the neural oxidative burden that contributes to dementias. Ann N Y Acad Sci, 1035: 179-196

77 Reyes-Toso C F, Rebagliati I R, Ricci C R, Linares L M, Albornoz L E, Cardinali D P, Zaninovich A (2006). Effect of melatonin treatment on oxygen consumption by rat liver mitochondria. Amino Acids, 31(3): 299-302

78 Reyes-Toso C F, Ricci C R, de Mignone I R, Reyes P, Linares L M, Albornoz L E, Cardinali D P, Zaninovich A (2003). In vitro effect of melatonin on oxygen consumption in liver mitochondria of rats. Neuro Endocrinol Lett, 24(5): 341-344

79 Rodríguez M I, Carretero M, Escames G, López L C, Maldonado M D, Tan D X, Reiter R J, Acuña-Castroviejo D (2007a). Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice. Free Radic Res, 41(1): 15-24

80 Rodríguez M I, Escames G, López L C, García J A, Ortiz F, López A, Acuña-Castroviejo D (2007b). Melatonin administration prevents cardiac and diaphragmatic mitochondrial oxidative damage in senescence-accelerated mice. J Endocrinol, 194(3): 637-643

81 Rodríguez M I, Escames G, López L C, López A, García J A, Ortiz F, Acuña-Castroviejo D (2007c). Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res, 42(3): 272-279

82 Rodríguez M I, Escames G, López L C, López A, García J A, Ortiz F, Sánchez V, Romeu M, Acuña-Castroviejo D (2008). Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol, 43(8): 749-756

83 Rosales-Corral S, Reiter R J, Tan D X, Ortiz G G, Lopez-Armas G (2010). Functional aspects of redox control during neuroinflammation. Antioxid Redox Signal, 13(2): 193-247

84 Samantaray S, Das A, Thakore N P, Matzelle D D, Reiter R J, Ray S K, Banik N L (2009). Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res, 47(2): 134-142

85 Sánchez-Hidalgo M, Guerrero Montávez J M, Carrascosa-Salmoral Mdel P, Naranjo Gutierrez Mdel C, Lardone P J, de la Lastra Romero C A (2009). Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging. J Pineal Res, 46(1): 29-35

86 Schaefer M, Hardeland R (2009). The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger. J Pineal Res, 46(1): 49-52

87 Semak I, Naumova M, Korik E, Terekhovich V, Wortsman J, Slominski A (2005). A novel metabolic pathway of melatonin: oxidation by cytochrome C. Biochemistry, 44(26): 9300-9307

88 Sewerynek E, Wiktorska J, Lewinski A (1999). Effects of melatonin on the oxidative stress induced by thyrotoxicosis in rats. Neuro Endocrinol Lett, 20(3-4): 157-161

89 Skulachev V P (2006). Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis, 11(4): 473-485

90 Sobreira C, Davidson M, King M P, Miranda A F (1996). Dihydrorhodamine 123 identifies impaired mitochondrial respiratory chain function in cultured cells harboring mitochondrial DNA mutations. J Histochem Cytochem, 44(6): 571-579

91 Srinivasan V, Pandi-Perumal S R, Maestroni G J, Esquifino A I, Hardeland R, Cardinali D P (2005). Role of melatonin in neurodegenerative diseases. Neurotox Res, 7(4): 293-318

92 Tan D X, Chen L D, Poeggeler B, Manchester L, Reiter R J (1993). Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J, 1: 57-60

93 Tan D X, Hardeland R, Manchester L C, Poeggeler B, Lopez-Burillo S, Mayo J C, Sainz R M, Reiter R J (2003). Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res, 34(4): 249-259

94 Tan D X, Manchester L C, Reiter R J, Plummer B F, Limson J, Weintraub S T, Qi W (2000a). Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med, 29(11): 1177-1185

95 Tan D X, Manchester L C, Reiter R J, Qi W B, Karbownik M, Calvo J R (2000b). Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept, 9(3-4): 137-159

96 Tan D X, Manchester L C, Terron M P, Flores L J, Reiter R J (2007). One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res, 42(1): 28-42

97 Tomás-Zapico C, Coto-Montes A (2005). A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res, 39(2): 99-104

98 Wang E, Wong A, Cortopassi G (1997). The rate of mitochondrial mutagenesis is faster in mice than humans. Mutat Res, 377(2): 157-166

99 Wei Y H, Ma Y S, Lee H C, Lee C F, Lu C Y (2001). Mitochondrial theory of aging matures—roles of mtDNA mutation and oxidative stress in human aging. Zhonghua Yi Xue Za Zhi (Taipei), 64(5): 259-270

100 Wei Y H, Wu S B, Ma Y S, Lee H C (2009). Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med J, 32(2): 113-132

101 Witt-Enderby P A, Bennett J, Jarzynka M J, Firestine S, Melan M A (2003). Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci, 72(20): 2183-2198

102 Wolkove N, Elkholy O, Baltzan M, Palayew M (2007). Sleep and aging: 1. Sleep disorders commonly found in older people. CMAJ, 176(9): 1299-1304

103 Wu Y H, Swaab D F (2005). The human pineal gland and melatonin in aging and Alzheimer’s disease. J Pineal Res, 38(3): 145-152

104 Wu Y H, Zhou J N, van Heerikhuize J, Jockers R, Swaab D F (2007). Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease. Neurobiol Aging, 28(8): 1239-1247

105 Yamamoto H A, Mohanan P V (2002). Melatonin attenuates brain mitochondria DNA damage induced by potassium cyanide in vivo and in vitro. Toxicology, 179(1-2): 29-36

106 Yamamoto H A, Mohanan P V (2003). Ganglioside GT1B and melatonin inhibit brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Brain Res, 964(1): 100-106